−320 KRW
5.84 B KRW
68.64 B KRW
15.31 M
About MEDIPOST CO., LTD.
Sector
Industry
CEO
Won-Il Oh
Website
Headquarters
Seongnam
Founded
2000
ISIN
KR7078160009
FIGI
BBG000F8XYW9
Medipost Co., Ltd. engages in the development and manufacture of stem cell biotechnology products. It operates through the following business divisions: Cord Blood Bank, Stem Cell Therapy, Health Functional Food, Import and Distribution of Natural Cosmetics and Healthcare Services. The Cord Blood Bank division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapy division manufactures allogeneic stem cell drug products. The Health Functional Food division offers vitamins and nutritional supplements. The Import and Distribution of Natural Cosmetics division is involved in the sales and marketing of natural cosmetics imported by Pevonia Inc. The Healthcare Services division provides healthcare solutions such as bizcare, insu-care, affiliate, telehealth services and medical devices through web, mobile, and call centers. The company was founded by Yoon-Sun Yang and Won-Il Oh on June 26, 2000 and is headquartered in Seongnam, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 078160 is 12,350 KRW — it has increased by 3.17% in the past 24 hours. Watch MEDIPOST CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange MEDIPOST CO., LTD. stocks are traded under the ticker 078160.
078160 stock has risen by 2.24% compared to the previous week, the month change is a 65.33% rise, over the last year MEDIPOST CO., LTD. has showed a 57.93% increase.
078160 reached its all-time high on Oct 18, 2011 with the price of 104,080 KRW, and its all-time low was 1,800 KRW and was reached on Oct 28, 2008. View more price dynamics on 078160 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
078160 stock is 5.81% volatile and has beta coefficient of 1.43. Track MEDIPOST CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is MEDIPOST CO., LTD. there?
Today MEDIPOST CO., LTD. has the market capitalization of 421.12 B, it has increased by 41.60% over the last week.
Yes, you can track MEDIPOST CO., LTD. financials in yearly and quarterly reports right on TradingView.
078160 net income for the last quarter is −18.21 B KRW, while the quarter before that showed 2.85 B KRW of net income which accounts for −738.64% change. Track more MEDIPOST CO., LTD. financial stats to get the full picture.
No, 078160 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 290.00 employees. See our rating of the largest employees — is MEDIPOST CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIPOST CO., LTD. EBITDA is −35.14 B KRW, and current EBITDA margin is −28.73%. See more stats in MEDIPOST CO., LTD. financial statements.
Like other stocks, 078160 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIPOST CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIPOST CO., LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIPOST CO., LTD. stock shows the buy signal. See more of MEDIPOST CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.